Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiawen Lv
Observed name:
J. Lv
Institutions:
Nanjing General Hospital of Nanjing Military Command,
Nanjing University
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Nanjing General Hospital of Nanjing Military Command,
Cancer Hospital of Chinese Academy of Medical Sciences,
Nanjing University
ORCID:
0000-0002-6799-7875
Observed ORCID:
0000-0002-6799-7875
OpenAlex ID:
A5072511334
Co-Delivery of VEGF siRNA and THPP via Metal–Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism
2024
·
Jiawen Lv
, Jiayan Chen
, et al.
·
ACS Applied Materials & Interfaces
·
14
CD39+CD8+ T cell infiltration is associated with clinical outcomes of subsequent immunotherapy in advanced EGFR-mutant non-small cell lung cancer
2026
·
Wanjun Lu
, Qiuxia Wu
, et al.
·
Therapeutic Advances in Medical Oncology
Dynamic Change of Systemic Inflammatory Score in Predicting Survival of Patient with Unresectable Stage III Non-Small Cell Lung Cancer Treated by Definitive Chemoradiotherapy with or without Consolidate Immunotherapy: A Single-Arm, Retrospective Study
2025
·
S. Luo
, Y. Yuan
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Primary Tumor Recurrence after Chemoradiotherapy in Limited Stage Small Cell Lung Cancer
2022
·
Y.R. Zhai
, W. Yan
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
4
Citation count:
14
H-index:
1
I10-index:
1
Year
Topic
Type